Li, Xiaoyi,Zhang, Guohui,Dai, Xiangrong,Ling, Juan,Wu, Yan
申请号：
AU2013247291
公开号：
AU2013247291A1
申请日:
2013.02.25
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
A lercanidipine hydrochloride and losartan potassium compound preparation. In terms of mass percentage, said compound preparation contains 0.5-40% lercanidipine hydrochloride and 6.25-50% losartan potassium. Also provided is a compound preparation which utilizes lercanidipine hydrochloride and losartan potassium as the main ingredient, lactose monohydrate, microcrystalline cellulose, A-type sodium starch glycollate, povidone K30, magnesium stearate, pregelatinized starch and colloidal silicon dioxide as excipients, and opadry white as a coating in the preparation of a tablet. Clinical tests show that compared with single-component preparations, said compound preparation markedly increases the effectiveness of treatment of light and moderate blood pressures, markedly reduces the incidence of adverse effects, is tolerated well by patients, and has excellent clinical application prospects.
